Literature DB >> 19528485

Frequent methylation of Vimentin in well-differentiated gastric carcinoma.

Yo-Hei Kitamura1, Atsushi Shirahata, Makiko Sakata, Tetsuhiro Goto, Hiroki Mizukami, Mitsuo Saito, Kazuyoshi Ishibashi, Gaku Kigawa, Hiroshi Nemoto, Yutaka Sanada, Kenji Hibi.   

Abstract

BACKGROUND: Recently, it was shown that the vimentin gene, usually activated in mesenchymal cells, was highly methylated in colorectal carcinoma.
MATERIALS AND METHODS: The methylation status of the vimentin gene was examined in primary carcinomas and the corresponding normal tissues derived from 37 patients with gastric carcinoma using quantitative methylation-specific PCR (qMSP) and the correlation between the methylation status and the clinicopathological findings was evaluated.
RESULTS: Aberrant methylation of the vimentin gene was detected in 14 out of 37 (38%) primary gastric carcinomas. This result suggested that the aberrant methylation of the vimentin gene was frequent in gastric carcinomas. Subsequently, clinicopathological data were correlated with the methylation score. A significant difference was observed in histology (p=0.0429). In addition, a trend was shown toward advancement of gastric carcinomas with vimentin methylation (p=0.0588).
CONCLUSION: In gastric carcinomas, well-differentiated adenocarcinoma was significantly methylated compared to poorly differentiated.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19528485

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  10 in total

1.  The role of vimentin as a methylation biomarker for early diagnosis of cervical cancer.

Authors:  Samil Jung; Lisha Yi; Jinsun Kim; Dongjun Jeong; Taejeong Oh; Chang-Hwan Kim; Chang-Jin Kim; Jin Shin; Sungwhan An; Myeong-Sok Lee
Journal:  Mol Cells       Date:  2011-04-08       Impact factor: 5.034

2.  Vimentin DNA methylation predicts survival in breast cancer.

Authors:  Jacob Ulirsch; Cheng Fan; George Knafl; Ming Jing Wu; Brett Coleman; Charles M Perou; Theresa Swift-Scanlan
Journal:  Breast Cancer Res Treat       Date:  2012-12-13       Impact factor: 4.872

3.  DNA hypermethylation of the vimentin gene inversely correlates with vimentin expression in intestinal- and diffuse-type gastric cancer.

Authors:  Hui Cong; Ru-Yong Yao; Zhen-Qing Sun; Wen-Sheng Qiu; Ya-Sai Yao; Tong-Tong Feng; Chao Xin; Jun Liang; L U Yue
Journal:  Oncol Lett       Date:  2015-11-18       Impact factor: 2.967

Review 4.  Circulating tumor cells in sarcomas: a brief review.

Authors:  Le Chang; Greg Asatrian; Sarah M Dry; Aaron W James
Journal:  Med Oncol       Date:  2014-12-10       Impact factor: 3.064

5.  Analysis of HGF, MACC1, C-met and apoptosis-related genes in cervical carcinoma mice.

Authors:  Xiao-Ping Chen; Xin-Ping Ren; Jian-Yun Lan; You-Guo Chen; Zong-Ji Shen
Journal:  Mol Biol Rep       Date:  2014-01-28       Impact factor: 2.316

Review 6.  The aberrant overexpression of vimentin is linked to a more aggressive status in tumours of the gastrointestinal tract.

Authors:  Marlena Brzozowa; Grzegorz Wyrobiec; Izabela Kołodziej; Mateusz Sitarski; Natalia Matysiak; Edyta Reichman-Warmusz; Małgorzata Żaba; Romuald Wojnicz
Journal:  Prz Gastroenterol       Date:  2015-01-14

Review 7.  Recent progress in the study of methylated tumor suppressor genes in gastric cancer.

Authors:  Xiao-Tong Hu; Chao He
Journal:  Chin J Cancer       Date:  2011-11-04

8.  Targeted deep sequencing of plasma circulating cell-free DNA reveals Vimentin and Fibulin 1 as potential epigenetic biomarkers for hepatocellular carcinoma.

Authors:  Reetta Holmila; Athena Sklias; David C Muller; Davide Degli Esposti; Paule Guilloreau; James Mckay; Suleeporn Sangrajrang; Petcharin Srivatanakul; Pierre Hainaut; Philippe Merle; Zdenko Herceg; Andre Nogueira da Costa
Journal:  PLoS One       Date:  2017-03-23       Impact factor: 3.240

9.  Synovial Sarcoma Microvesicles Harbor the SYT-SSX Fusion Gene Transcript: Comparison of Different Methods of Detection and Implications in Biomarker Research.

Authors:  A Fricke; P V Ullrich; A F V Cimniak; M Follo; S Nestel; B Heimrich; I Nazarenko; G B Stark; H Bannasch; D Braig; S U Eisenhardt
Journal:  Stem Cells Int       Date:  2016-03-16       Impact factor: 5.443

10.  High Resolution Based Quantitative Determination of Methylation Status of CDH1 and VIM Gene in Epithelial Ovarian Cancer.

Authors:  Gaurav Kr Thakur; Tusha Sharma; T Krishna Latha; B D Banerjee; Harendra Kr Shah; Kiran Guleria
Journal:  Asian Pac J Cancer Prev       Date:  2019-10-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.